The largest database of trusted experimental protocols

Virtuo

Manufactured by bioMérieux
Sourced in France

Virtuo is an automated blood culture system designed for the detection and identification of microorganisms in blood samples. The core function of Virtuo is to automate the blood culture process, providing efficient and accurate results to support clinical decision-making.

Automatically generated - may contain errors

4 protocols using virtuo

1

Blood Culture Identification and ESBL Detection

Check if the same lab product or an alternative is used in the 5 most similar protocols
During the study period the BACT/ALERT 3D and VIRTUO systems (both bioMérieux, Marcy-l’Étoile, France) were used to incubate aerobic and anaerobic blood culture flasks either with charcoal or raisins. Identification of ESBL-PE in bloodstream isolates was performed by standard culture methods in accordance to the guidelines of the Clinical and Laboratory Standards Institute [15 ]. Species were identified either with MALDI-TOF mass spectrometry (Bruker Daltonics, Bremen, Germany) or biochemically with the VITEK 2 system (bioMérieuex). Specific species within the K. pneumoniae group (K. pneumoniae, K. variicola, K. quasipneumoniae, and K. quasivariicola) could not be separated. The VITEK 2 system was also used for susceptibility testing. ESBL production was based on the detection of resistance to cefpodoxime, ceftriaxone, ceftazidime or aztreonam. Phenotypic confirmation of the ESBL test result was conducted by Etest strips (bioMérieuex) using cefotaxime, ceftazidime or cefepime, each tested with and without clavulanic acid or with Neo-Sensitabs discs (Rosco, Taastrup, Denmark). Minimum inhibitory concentration (MIC) breakpoints were interpreted according to EUCAST guidelines (www.eucast.org). ESBL was reported when at least two of three test substances showed evidence for ESBL.
+ Open protocol
+ Expand
2

Multiplex PCR for Meningitis Pathogens

Check if the same lab product or an alternative is used in the 5 most similar protocols
CFS specimens were processed according to standard microbiological procedures, including Gram stain and culture [19 (link)]. Multiplex PCR using the BioFire FilmArray® Meningitis/Encephalitis (ME) PCR Panel (Biomerieux, Salt Lake City, USA) was implemented in the routine in September 2016 and from that date was performed according to the manufacturer’s protocol and the laboratory diagnostic algorithm on CSF samples with ≥100 cells/mm3. The panel was used to detect 14 pathogens, including the following bacterial species: Escherichia coli, H. influenzae, Listeria monocytogenes, N. meningitidis, Streptococcus agalactiae, and S. pneumoniae. Blood cultures were performed by conventional systems, BacT/Alert 3D or Virtuo (BioMérieux, Durham, CA, USA). Isolates obtained from routine cultures were identified using standard methods and MALDI-TOF (Bruker, Bremen, Germany).
+ Open protocol
+ Expand
3

Blood Culture Isolation and Identification

Check if the same lab product or an alternative is used in the 5 most similar protocols
The analyzed strain was obtained from the Division of Clinical
Bacteriology and Mycology of the University Hospital Basel from a
routine diagnostics. The isolate originated from a blood culture.
Blood culture samples were incubated on a shaker (Virtuo, bioMérieux)
in respective blood culture bottles (BactAlert FA/FN, bioMérieux)
for a maximum of 6 days. The positive blood culture was subcultured
and the species were identified using MALDI-TOF mass spectrometry
(microflex, Bruker).
+ Open protocol
+ Expand
4

Rapid Detection of Meningitis Pathogens

Check if the same lab product or an alternative is used in the 5 most similar protocols
The BioFire FilmArray (FA; Idaho Technology, Inc., Salt Lake City, Utah) meningitis/encephalitis (ME) assay is the first FDA-approved PCR-array test that can simultaneously detect multiple pathogens in a single CSF specimen. The ME assay identifies 6 bacterial pathogens, including Escherichia coli k1, H. influenzae, L. monocytogenes, N. meningitidis, Streptococcus agalactiae and S. pneumoniae, and also 7 viral pathogens and 1 fungal pathogen [3 (link)]. The test has been used in TASMC since June 2016 for any case of suspected PCBM based on the discretion of the laboratory director. In general, the main criterion to use this test was when full course of antimicrobial therapy for bacterial meningitis was deemed necessary. In RMC, the test has been used since July 2017.
Bacterial cultures were done according to the American Society of Microbiology guidelines [20 ]. Bacterial identification was done using VITEK2® or VITEK-MS® systems; blood cultures were processed using BACT/ALERT® 3D® or VIRTUO® systems (bioMerieux, Marcy l’Etoile, France).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!